LungLife AI (LSE:LLA) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Days Payable?

LungLife AI's average Accounts Payable for the six months ended in Jun. 2024 was £0.29 Mil. LungLife AI's Cost of Goods Sold for the six months ended in Jun. 2024 was £0.00 Mil.

The historical rank and industry rank for LungLife AI's Days Payable or its related term are showing as below:

During the past 6 years, LungLife AI's highest Days Payable was 3373.10. The lowest was 1277.50. And the median was 1675.21.

LSE:LLA's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 60.71
* Ranked among companies with meaningful Days Payable only.

LungLife AI's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

LungLife AI Days Payable Historical Data

The historical data trend for LungLife AI's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Days Payable Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

1,490.42

1,277.50

1,860.00

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of LungLife AI's Days Payable

For the Diagnostics & Research subindustry, LungLife AI's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LungLife AI's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's Days Payable distribution charts can be found below:

* The bar in red indicates where LungLife AI's Days Payable falls into.

Save Embed

;

Save Embed

;

LungLife AI Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

LungLife AI's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.294	+	0.347)	/	2 )	/	0	*	365
=	0.3205					/	0	*	365
=	N/A

LungLife AI's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.347	+	0.223)	/	2 )	/	0	*	365 / 2
=	0.285					/	0	*	365 / 2
=	N/A

LungLife AI Days Payable Related Terms

Thank you for viewing the detailed overview of LungLife AI's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

LLAI:UK

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People's Republic of China and also has its presence in the United States of America.

LungLife AI Headlines

No Headlines